Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board
Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced the appointment of newly elected members of its Board of Directors (BOD) and the formation of a Scientific and Clinical...
Source: lelezard.com